KOBAYASHI Pharmaceutical Co.,Ltd.
SITEMAPJAPANESE
Top Page Company Profile Investors Products Contact Us
CONTENTS
Message from the CEO
Message from the COO
Corporate Profile
Medical Devices Operation Profile
International Operation Development
Development
Group Companies
News Release
NEWS RELEASE 2002
* Apr 23, 2002
Corporate name: Kobayashi Pharmaceutical Co., Ltd.
Chief Executive: Kazumasa KOBAYASHI, President & CEO
(Code No. 4967 The First Section of TSE/OSE)
Notice of amendment of the expected dividend for the March 2002 term
It is hereby notified that at the Directors' Meeting held on 28th April , 2002, the Company has resolved to amend the expected dividend per share as at the end of the current term as follows:

1. Reason for the amendment of the expected dividend per share
Assuming an increase in the net profit for the March 2002 term (from April 1, 2001 to March 31, 2002), the Company determines to raise the common dividend by \6.00 per stock as follows:

2.

Details of the amendment
(Unit: Yen)
  Interim End of the term End of the year
Projected dividend
(released on November 19, 2001)
0.00 12.50 12.50
Amended dividend 0.00 18.50 18.50
Previous dividend payout
(for the March 2001 term)
0.00 17.50 17.50
(N.B.) Dividend payout for the previous term was a common dividend of ¥12.50 per stock and dividend to commemorate listing on the Tokyo Stock Exchange of ¥5.00.
Back To Top


Copyright(c) 2008 Kobayashi Pharmaceutical Co., Ltd.